A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia
Status:
Unknown status
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the method (implanting stem cells derived
from peripheral blood after G-CSF mobilization) of treatment is safe and effective in the
management of diabetic foot ischemia, the therapeutic effect of stem cells is caused by
improving blood circulation in ischemic limb which would in turn promote ulcer healing,
prevent amputation of limb and relieve the Sevier pain of ischemia.